Literature DB >> 19025803

Average daily quantities: a tool for measuring prescribing volume in England.

T Walley1, D Roberts.   

Abstract

No perfect unit exists for measuring prescribing volume, because of the limitations of the prescription item and the Defined Daily Dose system. A specific English and easily understandable unit was thought desirable to allow discussions in the field with doctors about aspects of their prescribing. An expert group was therefore established to produce appropriate volume units (Average Daily Quantities, ADQs) for important drug groups, based on DDDs, average prescribed daily doses, and any available information on therapeutic equivalence. This system will be a useful tool for discussions with doctors concerning their prescribing. It is of some value for researchers performing drug utilization studies and studies on prescribing in England. The ADQ values will be reviewed regularly to ensure that changes in licensed doses, actual prescribing patterns, and DDDs are reflected, and that new drugs can be included. Copyright (c) 2000 John Wiley & Sons, Ltd.

Year:  2000        PMID: 19025803     DOI: 10.1002/(SICI)1099-1557(200001/02)9:1<55::AID-PDS467>3.0.CO;2-H

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  10 in total

1.  Comparison of national administrative and commercial databases to monitor expenditure and costs of statins across Europe.

Authors:  T Walley; P Folino-Gallo; U Schwabe; E Van Ganse; P Stephens
Journal:  Eur J Clin Pharmacol       Date:  2004-09       Impact factor: 2.953

2.  Variations in anxiolytic and hypnotic prescribing by GPs: a cross-sectional analysis using data from the UK Quality and Outcomes Framework.

Authors:  Zoi Tsimtsiou; Mark Ashworth; Roger Jones
Journal:  Br J Gen Pract       Date:  2009-06       Impact factor: 5.386

3.  Drug combinations and impaired renal function -- the 'triple whammy'.

Authors:  Katarzyna K Loboz; Gillian M Shenfield
Journal:  Br J Clin Pharmacol       Date:  2005-02       Impact factor: 4.335

4.  Continuity of long-term medication use after surgical hospital stay.

Authors:  I Hach; U Maywald; D Meusel; J U König; W Kirch
Journal:  Eur J Clin Pharmacol       Date:  2005-06-10       Impact factor: 2.953

5.  Antibiotic prescribing and patient satisfaction in primary care in England: cross-sectional analysis of national patient survey data and prescribing data.

Authors:  Mark Ashworth; Patrick White; Hannah Jongsma; Peter Schofield; David Armstrong
Journal:  Br J Gen Pract       Date:  2015-12-06       Impact factor: 5.386

6.  How equitable are GP practice prescribing rates for statins?: an ecological study in four primary care trusts in North West England.

Authors:  Paul R Ward; Peter R Noyce; Antony S St Leger
Journal:  Int J Equity Health       Date:  2007-03-27

7.  Exploring the equity of GP practice prescribing rates for selected coronary heart disease drugs: a multiple regression analysis with proxies of healthcare need.

Authors:  Paul R Ward; Peter R Noyce; Antony S St Leger
Journal:  Int J Equity Health       Date:  2005-02-08

8.  Influence of population and general practice characteristics on prescribing of minor tranquilisers in primary care.

Authors:  Andrew C Wagner; Mark Hann; Daren M Ashcroft
Journal:  Pharm Pract (Granada)       Date:  2010-03-15

9.  Modeling Seasonal and Spatiotemporal Variation: The Example of Respiratory Prescribing.

Authors:  Eleni Sofianopoulou; Tanja Pless-Mulloli; Stephen Rushton; Peter J Diggle
Journal:  Am J Epidemiol       Date:  2017-07-01       Impact factor: 4.897

10.  Differential associations between actual and expected GP practice prescribing rates for statins, ACE inhibitors, and beta-blockers: a cross-sectional study in England.

Authors:  Paul R Ward; Peter R Noyce; Antony S St Leger
Journal:  Ther Clin Risk Manag       Date:  2005-03       Impact factor: 2.423

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.